Orphan Drugs As A Lifeline for Rare Diseases
Nadiah Hanim Abdul Latif, President, Malaysia Rare Disorders Society | Professor Dr Thong Meow Keong, Consultant Paediatrician & Clinical Geneticist
15-Jan-25 16:00

Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
When speaking to individuals with rare disorders or their families, it’s not uncommon to hear about the diagnostic odyssey they’ve been through just to get a name for what they’re going through. But what happens after that? We want to look beyond the diagnosis, to understand what are the challenges they still face. Today, we’ll be exploring what access to medicines looks like for rare disorders and the importance of orphan drugs to these individuals and their families.
Image credit: Shutterstock
Produced by: Lim Sue Ann
Presented by: Lim Sue Ann
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: managing disease, wellness, health policy
Tags: the bigger picture, health and living, rare disease, orphan drugs, genetic diseases,